Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Horst

Showing results (121-130 of 221) with videos related to

Pageof 23
Sort By:
Cancers|October 14, 2022
Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian CancerJana Ihlow, Nanna Monjé, Inga Hoffmann, et al.
European Journal of Cancer (Oxford, England : 1990)|February 9, 2025
Characterizing uveal melanoma patients with peritoneal metastases: A retrospective single-center analysisStanislav Rosnev, Caroline A Peuker, Iris Piwonski, et al.
Journal of Personalized Medicine|March 26, 2025
Non-Small Cell Lung Cancer Patients with Skip-N2 Metastases Have Similar Survival to N1 Patients-A Multicenter AnalysisGeorg Schlachtenberger, Simon Schallenberg, Fabian Doerr, et al.
Egastroenterology|June 3, 2026
TERT rs10069690 variant is linked to reduced cholangiocarcinoma incidence but adverse prognosis in patients undergoing resectionIsabella Lurje, Justus Pein, Paul Horn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 7, 2019
DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancerPhilipp Jurmeister, Anne Schöler, Alexander Arnold, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 3, 2016
In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma componentsChristine Woischke, Christian W Schaaf, Hui-Min Yang, et al.
International Journal of Cancer|March 9, 2022
The single-cell transcriptional landscape of lung carcinoid tumorsPhilip Bischoff, Alexandra Trinks, Jennifer Wiederspahn, et al.
Science Signaling|July 22, 2025
Reporter-based screening identifies RAS-RAF mutations as drivers of resistance to active-state RAS inhibitors in colorectal cancerOleksandra Aust, Moritz R T Thiel, Eric Blanc, et al.
Journal of Neuro-Oncology|February 15, 2024
Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resectionDavid Wasilewski, Julia Onken, Paul Höricke, et al.
The Oncologist|April 8, 2026
Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patientDamian T Rieke, Stefan Schwartz, Sebastian Ochsenreither, et al.
Pageof 23

Showing results (121-130 of 221) with videos related to

Sort By:
Pageof 23
Cancers|October 14, 2022
Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian CancerJana Ihlow, Nanna Monjé, Inga Hoffmann, et al.
European Journal of Cancer (Oxford, England : 1990)|February 9, 2025
Characterizing uveal melanoma patients with peritoneal metastases: A retrospective single-center analysisStanislav Rosnev, Caroline A Peuker, Iris Piwonski, et al.
Journal of Personalized Medicine|March 26, 2025
Non-Small Cell Lung Cancer Patients with Skip-N2 Metastases Have Similar Survival to N1 Patients-A Multicenter AnalysisGeorg Schlachtenberger, Simon Schallenberg, Fabian Doerr, et al.
Egastroenterology|June 3, 2026
TERT rs10069690 variant is linked to reduced cholangiocarcinoma incidence but adverse prognosis in patients undergoing resectionIsabella Lurje, Justus Pein, Paul Horn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 7, 2019
DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancerPhilipp Jurmeister, Anne Schöler, Alexander Arnold, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 3, 2016
In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma componentsChristine Woischke, Christian W Schaaf, Hui-Min Yang, et al.
International Journal of Cancer|March 9, 2022
The single-cell transcriptional landscape of lung carcinoid tumorsPhilip Bischoff, Alexandra Trinks, Jennifer Wiederspahn, et al.
Science Signaling|July 22, 2025
Reporter-based screening identifies RAS-RAF mutations as drivers of resistance to active-state RAS inhibitors in colorectal cancerOleksandra Aust, Moritz R T Thiel, Eric Blanc, et al.
Journal of Neuro-Oncology|February 15, 2024
Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resectionDavid Wasilewski, Julia Onken, Paul Höricke, et al.
The Oncologist|April 8, 2026
Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patientDamian T Rieke, Stefan Schwartz, Sebastian Ochsenreither, et al.
Pageof 23